Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell TransplantationJonathan U. Peled, João B. Xavier, Melissa D. Docampo et al.|New England Journal of Medicine|2020Cited by 739
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trialNathan Fowler, Catherine Thiéblemont, Michael Dickinson et al.|Nature Medicine|2021Cited by 523
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant ResearchSally Arai, Yoshiko Atsuta, Mukta Arora et al.|Biology of Blood and Marrow Transplantation|2014Cited by 435
Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host DiseaseSaiko Kurosawa, Yoshiko Atsuta, Kumi Oshima et al.|Biology of Blood and Marrow Transplantation|2017Cited by 116
R-Spondin1 expands Paneth cells and prevents dysbiosis induced by graft-versus-host diseaseEiko Hayase, Takanori Teshima|The Journal of Experimental Medicine|2017Cited by 115